# Micron

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/micron

- Headquarters: Chengdu, China
- Latest round: Angel (Apr 8, 2023)
- Investors on record: 2

## About

Based in Chengdu, China and founded in 2022, Sichuan Micron Biotechnology Co., Ltd., trading as Micron, integrating product R&D, production, and sales, Micron utilizes microfluidic technology as its core, based on clinical needs, to build new systems and processes for emulsions, microspheres, and microcapsules with adjustable and controllable particle size, structure, and function. In November 2025, Micron raised a pre-series A+ funding from new investor BioTrack Capital.
The company provides groundbreaking, epoch-making, technologically innovative products, which are widely used in biomedicine, medical devices, and other fields. Micron has successfully developed the world's first microfluidic integrated system for mass production of microspheres, achieving industrial-grade mass production of microfluidically prepared microspheres. 
The company’s revenue is generated by providing microfluidic intelligent manufacturing technology.
The pre-series A+ funds will be used to accelerate the company's technology development and clinical project progress, injecting strong momentum into Microfluidics' industrialization journey.

## Funding rounds

- Angel, Apr 8, 2023 — China Financial Innovation Investment, BIO-TOWN Capital

## Investors

- China Financial Innovation Investment (https://capitalatlas.ai/funds/china-financial-innovation-investment) — Angel
- BIO-TOWN Capital (https://capitalatlas.ai/funds/bio-town-capital) — Angel